170 related articles for article (PubMed ID: 8659124)
21. [In vitro expression of wild type and precore mutant woodchuck hepatitis virus].
Lu Q; Zhang L; Liang C; Luo K
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):107-9. PubMed ID: 15619810
[TBL] [Abstract][Full Text] [Related]
22. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M
J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
[TBL] [Abstract][Full Text] [Related]
23. Experimental study on pathogenicity of precore mutants in Hepadnaviridae.
Ma Z; Wen Y; Xiong S; Zhai W; He L; Yao X
Chin Med J (Engl); 1998 Jun; 111(6):519-23. PubMed ID: 11245071
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B.
Kurosaki M; Enomoto N; Asahina Y; Sakuma I; Ikeda T; Tozuka S; Izumi N; Marumo F; Sato C
J Med Virol; 1996 Jun; 49(2):115-23. PubMed ID: 8991934
[TBL] [Abstract][Full Text] [Related]
25. Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide.
Frank I; Budde C; Fiedler M; Dahmen U; Viazov S; Lu M; Dittmer U; Roggendorf M
J Virol; 2007 Jul; 81(13):7156-63. PubMed ID: 17459928
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine.
Tatti KM; Korba BE; Stang HL; Peek S; Gerin JL; Tennant BC; Schinazi RF
Antiviral Res; 2002 Jul; 55(1):141-50. PubMed ID: 12076758
[TBL] [Abstract][Full Text] [Related]
27. Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection.
Siegel F; Lu M; Roggendorf M
J Virol; 2001 Jun; 75(11):5036-42. PubMed ID: 11333883
[TBL] [Abstract][Full Text] [Related]
28. Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy.
Shin JW; Chung YH; Choi MH; Kim JA; Ryu SH; Jang MK; Kim IS; Park NH; Lee HC; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2005 Jun; 20(6):844-9. PubMed ID: 15946130
[TBL] [Abstract][Full Text] [Related]
29. Out-of-frame versus in-frame core internal deletion variants of human and woodchuck hepatitis B viruses.
Sahu GK; Tai PC; Chatterjee SB; Lin MH; Tennant B; Gerin J; Shih C
Virology; 2002 Jan; 292(1):35-43. PubMed ID: 11878906
[TBL] [Abstract][Full Text] [Related]
30. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis.
Liu CJ; Kao JH; Lai MY; Chen PJ; Chen DS
J Med Virol; 2004 Apr; 72(4):545-50. PubMed ID: 14981756
[TBL] [Abstract][Full Text] [Related]
31. Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection.
Coffin CS; Pham TN; Mulrooney PM; Churchill ND; Michalak TI
Hepatology; 2004 Nov; 40(5):1053-61. PubMed ID: 15382154
[TBL] [Abstract][Full Text] [Related]
32. Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis.
Carman WF; Fagan EA; Hadziyannis S; Karayiannis P; Tassopoulos NC; Williams R; Thomas HC
Hepatology; 1991 Aug; 14(2):219-22. PubMed ID: 1860679
[TBL] [Abstract][Full Text] [Related]
33. A TaqMan PCR assay using degenerate primers for the quantitative detection of woodchuck hepatitis virus DNA of multiple genotypes.
Huang Z; Buckwold VE
Mol Cell Probes; 2005 Aug; 19(4):282-9. PubMed ID: 16005181
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of a p-glycoprotein in hepatocellular carcinomas from woodchuck hepatitis virus-infected woodchucks (Marmota monax).
Dunn SE; Hughes CS; LeBlanc GA; Cullen JM
Hepatology; 1996 Apr; 23(4):662-8. PubMed ID: 8666315
[TBL] [Abstract][Full Text] [Related]
35. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
[TBL] [Abstract][Full Text] [Related]
36. Genetic mutations of precore region of hepatitis B virus in hepatitis B e antigen-negative patients with fulminant hepatitis B and translation of precore variants in vitro.
Guo Y; Hou J; Luo K; Feng X
Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):42-4. PubMed ID: 11242136
[TBL] [Abstract][Full Text] [Related]
37. Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors.
Karayiannis P; Alexopoulou A; Hadziyannis S; Thursz M; Watts R; Seito S; Thomas HC
Hepatology; 1995 Dec; 22(6):1628-34. PubMed ID: 7489966
[TBL] [Abstract][Full Text] [Related]
38. Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma.
Liu CJ; Huang YJ; Chen HL; Lin HT; Lin HL; Kuo ML; Huang JL; Chen DS; Chen PJ; Wu HL
Genes Immun; 2009 Jan; 10(1):27-36. PubMed ID: 18971938
[TBL] [Abstract][Full Text] [Related]
39. Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine.
D'Ugo E; Kondili LA; Canitano A; Catone S; Giuseppetti R; Gallinella B; Palmieri G; Orobello S; Argentini C; Glück R; Rapicetta M
Vaccine; 2007 Jun; 25(26):4895-902. PubMed ID: 17531355
[TBL] [Abstract][Full Text] [Related]
40. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame.
Scaglioni PP; Melegari M; Wands JR
Virology; 1997 Jul; 233(2):374-81. PubMed ID: 9217060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
